Sight Sciences (SGHT) Asset Writedowns and Impairment (2020 - 2026)
Sight Sciences' (SGHT) quarterly Asset Writedowns and Impairment came in at -$28000.0 in Q1 2026, down 180.0% year-on-year from $35000.0 in Q1 2025, and down 127.72% quarter-over-quarter from $101000.0 in Q4 2025.
Sight Sciences (SGHT) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Sight Sciences' Asset Writedowns and Impairment history runs 7 years deep, the most recent figure standing at -$28000.0 for Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 180.0% year-over-year to -$28000.0 in Q1 2026; TTM through Mar 2026 was $66000.0, a 266.67% increase from a year earlier, with the FY2025 full-year figure at $129000.0, up 407.14% from the prior year.
- Asset Writedowns and Impairment eased to -$28000.0 in Q1 2026 per SGHT's latest filing, from $101000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $458000.0 in Q2 2023 and bottomed at -$250000.0 in Q1 2023.
- The 5-year median for Asset Writedowns and Impairment is $26000.0 (2025), against an average of $51705.9.
- Across the five-year window, Asset Writedowns and Impairment slumped 3225.0% in 2023 and surged 3050.0% in 2024, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $7000.0 in 2022, then plunged by 71.43% to $2000.0 in 2023, then jumped by 3050.0% to $63000.0 in 2024, then jumped by 60.32% to $101000.0 in 2025, then slumped by 127.72% to -$28000.0 in 2026.
- Per Business Quant, the three latest SGHT Asset Writedowns and Impairment figures stand at -$28000.0 (Q1 2026), $101000.0 (Q4 2025), and -$33000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | Sight Sciences | 278.62 Mn | 193.65 Mn | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28,000.00 |
| Mar 31, 2026 | -28,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | -209,000.00 |
| Sep 30, 2024 | -209,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | -25,000.00 |
| Mar 31, 2024 | -25,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |